ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Palatin Technologies Inc New

Palatin Technologies Inc New (PTN)

1.66
0.01
( 0.61% )
Updated: 10:38:41

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
1.66
Bid
-
Ask
-
Volume
10,285
1.66 Day's Range 1.69
1.43 52 Week Range 5.65
Market Cap
Previous Close
1.65
Open
1.69
Last Trade
161
@
1.66
Last Trade Time
10:39:11
Financial Volume
$ 17,291
VWAP
1.6812
Average Volume (3m)
107,718
Shares Outstanding
16,136,640
Dividend Yield
-
PE Ratio
-0.99
Earnings Per Share (EPS)
-1.71
Revenue
5.88M
Net Profit
-27.54M

About Palatin Technologies Inc New

Palatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs and commercial potential. Its programs are based on molecules that modulate the activity of the me... Palatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its main product in clinical development is bremelanotide, which treats hypoactive sexual desire disorder, which is a type of female sexual dysfunction. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Palatin Technologies Inc New is listed in the Pharmaceutical Preparations sector of the American Stock Exchange with ticker PTN. The last closing price for Palatin Technologies was $1.65. Over the last year, Palatin Technologies shares have traded in a share price range of $ 1.43 to $ 5.65.

Palatin Technologies currently has 16,136,640 shares outstanding. The market capitalization of Palatin Technologies is $26.63 million. Palatin Technologies has a price to earnings ratio (PE ratio) of -0.99.

PTN Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.02-1.190476190481.681.871.611109871.72347959CS
4-0.22-11.70212765961.881.961.61853661.74678477CS
12-0.42-20.19230769232.082.481.611077181.97490365CS
26-3.47-67.64132553615.135.221.463914542.40002368CS
52-0.23-12.16931216931.895.651.432960422.58065689CS
1561.15225.4901960780.518.60.181111438030.81123018CS
2600.726377.78729784730.93378.60.181116228810.75659476CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NVDXT Rex 2X Long NVIDIA Daily Target ETF
$ 13.988
(22.38%)
3.42M
USDProShares Ultra Semiconductors
$ 118.80
(16.39%)
366.38k
FLYXflyExclusive Inc
$ 4.8299
(15.00%)
1.35k
SOXLDirexion Daily Semiconductor Bull 3X Shares
$ 42.63
(14.47%)
36.38M
TECLDirexion Daily Technology Bull 3X Shares
$ 83.74
(11.16%)
758.57k
BTCGrayscale Bitcoin Mini Trust BTC
 5.8938
(-94.05%)
320.22k
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF
$ 6.2299
(-22.08%)
8.34M
SSGProShares UltraShort Semiconductors New
$ 7.91
(-16.74%)
168.83k
SOXSDirexion Daily Semiconductor Bear 3X Shares New
$ 25.07
(-14.55%)
20.87M
TOVXTheriva Biologics Inc
$ 0.2384
(-14.24%)
6.17M
SOXLDirexion Daily Semiconductor Bull 3X Shares
$ 42.63
(14.47%)
36.38M
SOXSDirexion Daily Semiconductor Bear 3X Shares New
$ 25.07
(-14.55%)
20.87M
TELLTellurian Inc
$ 0.9249
(-0.28%)
17.88M
SPXSDirexion Daily S&P 500 Bear 3X Shares New
$ 7.6082
(-5.25%)
12.66M
TZADirexion Daily Small Cap Bear 3X Share New
$ 13.62
(-1.52%)
12.34M

PTN Discussion

View Posts
Monksdream Monksdream 2 weeks ago
PTN under $2
πŸ‘οΈ0
Monksdream Monksdream 4 weeks ago
PTN under $2
πŸ‘οΈ0
mike1986 mike1986 4 months ago
You may just get your wish. This stock has been making promises for years and now expects everyone to wait until 2025 for any hope of marketing its dry eye ointment, while looking for a partner to do the heavy lifting. Ahhhhhhh..........
πŸ‘οΈ0
Stockexpertpro Stockexpertpro 4 months ago
PTN Palatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease (DED) Clinical Data Results Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2024

https://finance.yahoo.com/news/palatin-announces-phase-3-pl9643-113000533.html
πŸ‘οΈ0
zeusgodmd zeusgodmd 4 months ago
Waiting for 1.25
πŸ‘οΈ0
Monksdream Monksdream 4 months ago
PTN under $2
πŸ‘οΈ0
mte1955 mte1955 5 months ago
Well just great. Pump it the few days before the announcement and sell it on the news.
πŸ‘οΈ0
mike1986 mike1986 5 months ago
I love the way these low cap stocks move up and down on no news.
πŸ‘οΈ0
mike1986 mike1986 5 months ago
On the move with high volume. Hope something announced soon.
👍️ 1
mte1955 mte1955 5 months ago
So I guess people are disappointed with the latest report. Nothing new but nothing detrimental either.
πŸ‘οΈ0
zeusgodmd zeusgodmd 6 months ago
Did not see that coming. Why can’t they what. Til after the news
πŸ‘οΈ0
zeusgodmd zeusgodmd 6 months ago
Guess no news this week
πŸ‘οΈ0
zeusgodmd zeusgodmd 7 months ago
There are people here that seem to start buying 3 days before a big announcement but everybody is looking at before the end of the year will see
πŸ‘οΈ0
power11 power11 7 months ago
ANY SPECIFIC DATE ???
THANKS
πŸ‘οΈ0
zeusgodmd zeusgodmd 7 months ago
News next week
πŸ‘οΈ0
zeusgodmd zeusgodmd 9 months ago
Good luck in am. Need a new partner to launch eye sauce. Royalty payments with a down payment. New sex med, new Ibs med why are we at 2$
πŸ‘οΈ0
zeusgodmd zeusgodmd 9 months ago
It was going a nice direction why fk it up.
πŸ‘οΈ0
mike1986 mike1986 9 months ago
Seems more like unloading today. Buy the rumor, sell the news.
πŸ‘οΈ0
zeusgodmd zeusgodmd 9 months ago
Highest volume in over a year will take it. Money managers starting the load
πŸ‘οΈ0
zeusgodmd zeusgodmd 9 months ago
Stepping up the right way
πŸ‘οΈ0
zeusgodmd zeusgodmd 9 months ago
It’s only up one buck a lot more money to be made
πŸ‘οΈ0
johnb214 johnb214 9 months ago
All time is around 1,670.00. A large Pharma should buy the stock and acquire it versus just paying for one or two of their drugs.
πŸ‘οΈ0
zeusgodmd zeusgodmd 9 months ago
Nice moves not 8 yet
πŸ‘οΈ0
zeusgodmd zeusgodmd 9 months ago
Last 3 days tells the story people loading the boat
πŸ‘οΈ0
zeusgodmd zeusgodmd 9 months ago
Hw investors calling for 75$ I’ve seen that call once by them at it was right on rambus stock
πŸ‘οΈ0
zeusgodmd zeusgodmd 9 months ago
Not to 8$ yet
πŸ‘οΈ0
zeusgodmd zeusgodmd 9 months ago
Will take shorts 5 days to cover. Good run
πŸ‘οΈ0
zeusgodmd zeusgodmd 9 months ago
Stock going to get out of the shitter soon should be 8$
πŸ‘οΈ0
zeusgodmd zeusgodmd 9 months ago
They need to start looking for a marketing and sale partnership for eye product and Ibs product
πŸ‘οΈ0
zeusgodmd zeusgodmd 9 months ago
Good loading day. Good news will come.
πŸ‘οΈ0
zeusgodmd zeusgodmd 10 months ago
Maybe falls to floor tomorrow time to buy good luck to sll
πŸ‘οΈ0
zeusgodmd zeusgodmd 10 months ago
It time for them to get in bed with a eye company and get some funding and royalty plans with them.
👍️ 1
Monksdream Monksdream 10 months ago
PTN under $2
πŸ‘οΈ0
zeusgodmd zeusgodmd 11 months ago
Let’s see 2.00
πŸ‘οΈ0
zeusgodmd zeusgodmd 12 months ago
Will see 220 soon
πŸ‘οΈ0
mike1986 mike1986 12 months ago
Buy on the rumor, sell on the news!
πŸ‘οΈ0
mike1986 mike1986 12 months ago
Nice move last few day. Congratulations to the faithful!
πŸ‘οΈ0
zeusgodmd zeusgodmd 1 year ago
Bad new coming I quess
πŸ‘οΈ0
AJ Freely AJ Freely 1 year ago
$PTN - Up 8% Pre-Market/ Current Price $2.44
Announces Preliminary Fourth Quarter Fiscal 2023 Vyleesi® Product Revenue Results
??31% growth over 2Q '23; 165% growth over 3Q '22
πŸ‘οΈ0
zeusgodmd zeusgodmd 1 year ago
Nice day something up
πŸ‘οΈ0
zeusgodmd zeusgodmd 1 year ago
Yes there’s only like 11 million shares to this company and maybe 8 million warrants at higher prices. They have 3 good pipeline s of new drugs. First one will shoot it to 30 once nda gets approval. This one should be 8$ already with the low float. It will be bought and taken out buy a big eye company and the ulcerative colitis will be bought or co sold with Merck or another big boy wait and see
πŸ‘οΈ0
stevenjklein stevenjklein 1 year ago
PTN Palatin Technologies, Inc.

Stock Split History (link goes to Seeking Alpha)

Date Ratio
Aug. 31, 2022 1:25
Sep. 27, 2010 1:10
Sep. 08, 1997 1:4
Jul. 22, 1996 1:10
πŸ‘οΈ0
zeusgodmd zeusgodmd 1 year ago
The board has to get there shares before the company gets sold. Now set the price
πŸ‘οΈ0
zeusgodmd zeusgodmd 1 year ago
I think we will see in next year no problem when products go to nda they will be bought buy a big guy or partners with ability to buy Ibs drug also that is where the stock will shoot the gap
πŸ‘οΈ0
mike1986 mike1986 1 year ago
Well at $8 I am ahead. $ 20 makes this a home run.
πŸ‘οΈ0
zeusgodmd zeusgodmd 1 year ago
They also did a 20 for one stock split to shares trading at 10 cents it will go up fast with good news. Should be 8$ by now
πŸ‘οΈ0
zeusgodmd zeusgodmd 1 year ago
Company’s future and products. If they start selling sex drug Europe then profits going up. But there pipeline is in stage 2 and 3 drugs with eye drug will be a good deal with all the old people in the USA. Those drugs are expensive any eye drops. They will partner up with some big company for there sales force and probably get a payment up front and royalties then the Ibs drug comes out of the pipe game on. HW a research company has company valued at 75$ a share.
πŸ‘οΈ0
mike1986 mike1986 1 year ago
You have any idea why the stock has been strong the past two days. I saw nothing in the quarterly report that was dramatic but maybe I missed something.
πŸ‘οΈ0
zeusgodmd zeusgodmd 1 year ago
We need a company to join and help market eye drops and we go up.
πŸ‘οΈ0
zeusgodmd zeusgodmd 1 year ago
New after hours didn’t know they where starting to ramp up sex drug sales overseas but 2 companies going for it.
πŸ‘οΈ0